Cargando…

Sleep Alterations in a Mouse Model of Spinocerebellar Ataxia Type 3

Spinocerebellar ataxia type 3 (SCA3) is a neurodegenerative disorder showing progressive neuronal loss in several brain areas and a broad spectrum of motor and non-motor symptoms, including ataxia and altered sleep. While sleep disturbances are known to play pathophysiologic roles in other neurodege...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsimpanouli, Maria-Efstratia, Ghimire, Anjesh, Barget, Anna J., Weston, Ridge, Paulson, Henry L., Costa, Maria do Carmo, Watson, Brendon O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563426/ https://www.ncbi.nlm.nih.gov/pubmed/36231095 http://dx.doi.org/10.3390/cells11193132

Ejemplares similares

Regional and age-dependent changes in ubiquitination in cellular and mouse models of spinocerebellar ataxia type 3
por: Luo, Haiyang, et al.
Publicado: (2023)

Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias
por: Gan, Shi-Rui, et al.
Publicado: (2017)

Mood alterations in mouse models of Spinocerebellar Ataxia type 1
por: Asher, Melissa, et al.
Publicado: (2021)

Spinocerebellar ataxia: an update
por: Sullivan, Roisin, et al.
Publicado: (2018)

The cholinesterase inhibitor donepezil has antidepressant-like properties in the mouse forced swim test
por: Fitzgerald, Paul J., et al.
Publicado: (2020)

Axonal inclusions in spinocerebellar ataxia type 3
por: Seidel, Kay, et al.
Publicado: (2010)

Blood levels of neurofilament light are associated with disease progression in a mouse model of spinocerebellar ataxia type 3
por: Mengel, David, et al.
Publicado: (2023)

An understanding of spinocerebellar ataxia
por: Ramachandra, N.B., et al.
Publicado: (2015)

Parkinsonism in Spinocerebellar Ataxia
por: Park, Hyeyoung, et al.
Publicado: (2015)

Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3
por: Rodríguez-Cueto, Carmen, et al.
Publicado: (2017)

Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways
por: Zeng, Li, et al.
Publicado: (2018)

Vascular Risk Factors and Clinical Progression in Spinocerebellar Ataxias
por: Lo, Raymond Y., et al.
Publicado: (2015)

Functionality and disease severity in spinocerebellar ataxias
por: da CRUZ, Geanison Castro, et al.
Publicado: (2022)

Cell biology of spinocerebellar ataxia
por: Orr, Harry T.
Publicado: (2012)

Cognitive dysfunction in spinocerebellar ataxias
por: Teive, Helio Afonso Ghizoni, et al.
Publicado: (2009)

Neuroradiological Findings in the Spinocerebellar Ataxias
por: Meira, Alex Tiburtino, et al.
Publicado: (2019)

Quantitative evaluation of upper limb ataxia in spinocerebellar ataxias
por: Kishimoto, Yoshiyuki, et al.
Publicado: (2022)

Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities
por: Fitzgerald, Paul J., et al.
Publicado: (2021)

Spinocerebellar Ataxia 12 Patients have better Quality of Life than Spinocerebellar Ataxia 1 and 2
por: Dabla, Surekha, et al.
Publicado: (2022)

The Multiple Faces of Spinocerebellar Ataxia type 2
por: Antenora, Antonella, et al.
Publicado: (2017)

‘Costa da Morte’ ataxia is spinocerebellar ataxia 36: clinical and genetic characterization
por: García-Murias, María, et al.
Publicado: (2012)

Genetic and molecular aspects of spinocerebellar ataxias
por: Honti, Viktor, et al.
Publicado: (2005)

Decreasing fall risk in spinocerebellar ataxia
por: Santos de Oliveira, Laura Alice, et al.
Publicado: (2015)

Spinocerebellar ataxia-10 with paranoid schizophrenia
por: Trikamji, Bhavesh, et al.
Publicado: (2015)

Spinocerebellar Ataxia Type 31 with Blepharospasm
por: Itaya, Sakiko, et al.
Publicado: (2018)

Diagnosis of Spinocerebellar Ataxia in the West Indies
por: Yearwood, Ashley K., et al.
Publicado: (2018)

Nonmotor symptoms in spinocerebellar ataxias (SCAs)
por: Moro, Adriana, et al.
Publicado: (2019)

Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias
por: Robinson, Katherine J., et al.
Publicado: (2020)

Respiratory dysfunction in a mouse model of spinocerebellar ataxia type 7
por: Fusco, Anna F., et al.
Publicado: (2021)

Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex
por: Luttik, Kimberly, et al.
Publicado: (2022)

Accumulation of senescence observed in spinocerebellar ataxia type 7 mouse model
por: Miller, William, et al.
Publicado: (2022)

Experimental Treatment with Edaravone in a Mouse Model of Spinocerebellar Ataxia 1
por: Sucha, Martina, et al.
Publicado: (2023)

Temporal Dynamics of the Scale for the Assessment and Rating of Ataxia in Spinocerebellar Ataxias
por: Moulaire, Paul, et al.
Publicado: (2022)

Histone deacetylase-3 interacts with ataxin-7 and is altered in a spinocerebellar ataxia type 7 mouse model
por: Duncan, Carlotta E, et al.
Publicado: (2013)

Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7
por: Nambo-Venegas, Rafael, et al.
Publicado: (2020)

Deletion at ITPR1 Underlies Ataxia in Mice and Spinocerebellar Ataxia 15 in Humans
por: van de Leemput, Joyce, et al.
Publicado: (2007)

Derivation of spinocerebellar ataxia type 3 human embryonic stem cell line UMICHe001-A/UM134-1
por: Moore, Lauren R., et al.
Publicado: (2022)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Neurochemical Differences in Spinocerebellar Ataxia Type 14 and 1
por: Grosch, Anne Sophie, et al.
Publicado: (2020)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_75dv4m6dtpg3n8n0dm9es55576